Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists

Documenti analoghi

• LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy
  di: Sangjon Pae, et al.
  Pubblicazione: (2025)
• Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
  di: Trevor C. Hunt, et al.
  Pubblicazione: (2025)
• Nonantibiotic strategies to decrease the postbiopsy hospitalization rates because of infectious complications after transrectal prostate biopsy
  di: Coşkun Bostancı
  Pubblicazione: (2024)
• Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
  di: Shuhei Kamada, et al.
  Pubblicazione: (2024)
• Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid‐Induced Inflammation and Pro‐Survival Pathways
  di: Nibrass Taher Abdali, et al.
  Pubblicazione: (2025)